Jeffrey S. Wefel, Renato Lenzi, Richard Theriault, Aman U. Buzdar, Scott Cruickshank and Christina A. Meyers ‘Chemobrain’ in breast carcinoma? Cancer 101
Version of Record online: 21 JUN 2004 | DOI: 10.1002/cncr.20393
Approximately 35% of women with breast carcinoma exhibited impaired cognitive function before receiving chemotherapy. The authors examined potential demographic, disease-related, and clinical factors associated with impaired cognitive function and discussed the implications for chemotherapy trial design.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field